Skip to main content
Premium Trial:

Request an Annual Quote

LGC to Distribute NuGen Target Enrichment Technology

NEW YORK (GenomeWeb) – Life science company LGC has signed an agreement to offer NuGen's single-primer enrichment technology (SPET) for next-generation sequencing target enrichment, the companies announced today.

SPET is designed for the targeted sequencing of both DNA and RNA, and enables applications such as the detection of germline and somatic aberrations for molecular diagnostics and targeted genotyping for animal and plant breeding, according to NuGen.

Under the terms of the deal, LGC will offer the technology through its recently launched SeqSNP targeted genotyping service for animal and plant breeding. It will also distribute NuGen's SPET-based Allegro Targeted Genotyping kits — which are used for targeted genotyping-by-sequencing on a variety of organisms via NGS — for use in local laboratories.

Additional terms were not disclosed.

"We developed Allegro as a tool for high-throughput, large-scale targeted genotyping, and the agrigenomics market is a perfect fit," NuGen CEO Nitin Sood said in a statement. "We are excited to have an experienced partner like LGC making Allegro Targeted Genotyping available to a broader audience."

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.